The private market segment grew 25% YoY in H1FY26, demonstrating resilience. However, the government segment (B2G) saw a temporary dip as 4 major tenders were deferred to H2, leadi...

Consolidated revenues grew 120% YoY in H1 FY26 to INR 110 Cr. This was primarily driven by the Preventive Healthcare segment, which saw high adoption of wellness and mental health ...

Standalone revenue from operations reached INR 106.53 Cr in FY2025, a marginal growth of 0.87% YoY from INR 105.61 Cr. Revenue is driven by JMS products (50-55% of total), renal ca...

Total revenue for FY 2024-25 was INR 63 Cr, up 12.5% YoY. For H1 FY26, revenue from operations reached INR 34.41 Cr, a 16.14% YoY increase. Export revenue grew by 24% YoY in H1 FY2...